Coeptis Therapeutics Holdings, Inc. - Common Stock (COEP)
Financial Services › Finance Services
Price History
Feb 9, 2026 — Mar 26, 2026Investment Snapshot
- P/B of 5.13 — trading above book value
- Piotroski F-Score 6/9 — moderate financial health
- Loss-making — negative ROE of -92.0%
Coeptis Therapeutics Holdings, Inc. - Common Stock (COEP) is a Financial Services company operating in Finance Services, listed on the NASDAQ , with a market capitalisation of $70 million . Key value metrics: P/B ratio 5.13, Piotroski F-Score 6 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Coeptis Therapeutics Holdings, Inc. - Common Stock — Fundamental Analysis Summary
On financial health, COEP shows a moderate Piotroski F-Score of 6/9, and negative return on equity of -92.0% (sector average: 5.8%), and minimal leverage with a debt-to-equity ratio of 0.01.
StockPik's composite Value Score for COEP is 49/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
COEP reports a high gross margin of 73.0% (sector average: 9.2%) and a negative operating margin of -2,634.2%.
COEP shows earnings declining at 10%.